MTCH
37
7
FDX
36
-4
AMGN
44
5
TDC
75
4
KR
34
-3
WAT
47
5
DVA
72
2
NAVI
41
-3
SWK
56
-2
ABT
57
-5
VTR
49
-3
NTAP
64
2
EFX
32
2
EQT
59
2
PEP
41
6
GM
65
-3
SYF
85
2
UNH
61
6
URI
53
-2
ACN
47
-2
MTCH
37
7
FDX
36
-4
AMGN
44
5
TDC
75
4
KR
34
-3
WAT
47
5
DVA
72
2
NAVI
41
-3
SWK
56
-2
ABT
57
-5
VTR
49
-3
NTAP
64
2
EFX
32
2
EQT
59
2
PEP
41
6
GM
65
-3
SYF
85
2
UNH
61
6
URI
53
-2
ACN
47
-2
Financhill
Back

Myriad Genetics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
16

MYGN
Myriad Genetics

Last Price:
15.00
Seasonality Move:
18.24%
Sell
30

CATX
Perspective Therapeutics

Last Price:
2.96
Seasonality Move:
34.33%
Sell
16
Myriad Genetics (MYGN) is a Sell

Is Myriad Genetics a Buy, Sell or Hold?

  • The current Myriad Genetics [MYGN] share price is $15.30. The Score for MYGN is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • MYGN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MYGN Stock Price Chart

What is Myriad Genetics's stock price today?

  • The Myriad Genetics share price today is $15.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MYGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $6.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

MYGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.29 Sell
Relative Strength Index (14 RSI): 19.49 Sell
Chaikin Money Flow: 619490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.08 - 22.24) Sell
Bollinger Bands (100): (21.09 - 28.73) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 14.63 Sell
Chaikin Money Flow: -723713 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.98 - 12.88) Sell
Bollinger Bands (100): (10.81 - 14.53) Sell

MYGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.71 Sell
20-day SMA: 18.2 Sell
50-day SMA: 22.79 Sell
200-day SMA: 23.48 Sell
8-day EMA: 15.86 Sell
20-day EMA: 17.95 Sell
50-day EMA: 21.27 Sell
200-day EMA: 22.98 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.55 Sell
20-day SMA: 10.54 Sell
50-day SMA: 12.08 Sell
200-day SMA: 12.78 Sell
8-day EMA: 8.2 Sell
20-day EMA: 9.96 Sell
50-day EMA: 11.52 Sell
200-day EMA: 11.52 Sell

Myriad Genetics Earnings Growth & MYGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.44 per share, and an increase next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Myriad Genetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):